CN120826394A - 作为sarm1抑制剂的经取代的1h-吡唑-4-甲酰胺 - Google Patents

作为sarm1抑制剂的经取代的1h-吡唑-4-甲酰胺

Info

Publication number
CN120826394A
CN120826394A CN202480020068.8A CN202480020068A CN120826394A CN 120826394 A CN120826394 A CN 120826394A CN 202480020068 A CN202480020068 A CN 202480020068A CN 120826394 A CN120826394 A CN 120826394A
Authority
CN
China
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
compound according
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480020068.8A
Other languages
English (en)
Chinese (zh)
Inventor
A·S·布里尔利
R·德芙拉伊
R·O·休斯
S·A·帕罗特
T·波萨纳奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Disarm Therapeutics Inc
Original Assignee
Disarm Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Disarm Therapeutics Inc filed Critical Disarm Therapeutics Inc
Publication of CN120826394A publication Critical patent/CN120826394A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202480020068.8A 2023-01-24 2024-01-18 作为sarm1抑制剂的经取代的1h-吡唑-4-甲酰胺 Pending CN120826394A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363481202P 2023-01-24 2023-01-24
US63/481202 2023-01-24
PCT/US2024/011943 WO2024158607A1 (en) 2023-01-24 2024-01-18 Substituted 1h-pyrazole-4-carboxamides as sarm1 inhibitors

Publications (1)

Publication Number Publication Date
CN120826394A true CN120826394A (zh) 2025-10-21

Family

ID=89983825

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480020068.8A Pending CN120826394A (zh) 2023-01-24 2024-01-18 作为sarm1抑制剂的经取代的1h-吡唑-4-甲酰胺

Country Status (6)

Country Link
EP (1) EP4655295A1 (https=)
JP (1) JP2026503618A (https=)
CN (1) CN120826394A (https=)
AR (1) AR131685A1 (https=)
TW (1) TW202444700A (https=)
WO (1) WO2024158607A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025243724A1 (ja) * 2024-05-20 2025-11-27 国立研究開発法人国立精神・神経医療研究センター 神経保護剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112839647B (zh) 2018-06-07 2025-09-23 达萨玛治疗公司 Sarm1抑制剂
WO2021142006A1 (en) 2020-01-07 2021-07-15 Disarm Therapeutics, Inc. Inhibitors of sarm1

Also Published As

Publication number Publication date
AR131685A1 (es) 2025-04-23
WO2024158607A1 (en) 2024-08-02
JP2026503618A (ja) 2026-01-29
TW202444700A (zh) 2024-11-16
EP4655295A1 (en) 2025-12-03

Similar Documents

Publication Publication Date Title
KR102793183B1 (ko) 헤테로시클릭 rip1 키나제 억제제
JP6918088B2 (ja) Gpr139のモジュレーターとしての4−オキソ−3,4−ジヒドロ−1,2,3−ベンゾトリアジン
US8338437B2 (en) Amines as small molecule inhibitors
EP2102210B1 (en) Compounds useful as protein kinase inhibitors
US9738630B2 (en) Inhibitors of lysine methyl transferase
JP5498703B2 (ja) プロテインキナーゼのインヒビターとして有用なチオフェン−カルボキサミド
AU2009345802B2 (en) Phenoxymethyl heterocyclic compounds
EP3653620B1 (en) New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2)
AU2009262241A1 (en) 1, 2 disubstituted heterocyclic compounds
CN108290897A (zh) 一类取代三唑并哌嗪类parp抑制剂及其制备方法和用途
CN101448832A (zh) 醛固酮合酶和/或11β-羟化酶抑制剂
TWI448465B (zh) 乙炔基衍生物
CZ20023945A3 (cs) Substituované pyrrolopyridinové deriváty pro použití jako inhibitory fosfodiesterázy
EP1087978A1 (fr) Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique
CN105517549B (zh) CaMKII抑制剂和其用途
AU3732700A (en) Fused pyridopyridazine inhibitors of cgmp phosphodiesterase
JP2019509272A (ja) 脊髄性筋萎縮症の治療のための併用療法
AU2007338574A1 (en) Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase
CN113166105B (zh) 作为cdk-hdac双通路抑制剂的杂环化合物
CN100402521C (zh) 4-咪唑啉-2-酮化合物
CN117756812A (zh) 一类prmt5抑制剂及其用途
JP2010510216A (ja) プロテインキナーゼのインヒビターとして有用な化合物
KR20190040763A (ko) 피라졸로피리딘 유도체 화합물 및 이의 용도
CN120826394A (zh) 作为sarm1抑制剂的经取代的1h-吡唑-4-甲酰胺
WO2017073743A1 (ja) 三環性化合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination